外用抗菌剂替代抗生素治疗脓疱疮(TIARA)试验:新西兰社会经济弱势社区学校卫生诊所的单盲随机对照试验
该方案介绍一项非劣效性单盲随机对照试验,在新西兰城市中心学校卫生诊所比较外用夫西地酸、外用过氧化氢与单纯伤口护理治疗儿童脓疱疮,受试者随机接受5天治疗,主要结局为盲法评分者通过配对照片评估的临床改善,并比较治疗前后抗菌药物耐药模式。
要点
- 该试验比较外用夫西地酸、外用过氧化氢与单纯伤口护理治疗儿童脓疱疮。
- 受试者随机接受5天治疗,主要结局为盲法评分者通过配对照片评估的临床改善。
- 试验同时比较治疗前后抗菌药物耐药模式,并强调让受脓疱疮影响最大的社区参与试验设计与实施。
核心结论
- 该方案旨在比较外用夫西地酸、外用过氧化氢与单纯伤口护理治疗儿童脓疱疮的效果,并比较治疗前后抗菌药物耐药模式。
研究设计与样本
- 非劣效性、单盲随机对照试验,设在新西兰一个城市中心的学校卫生诊所,比较外用夫西地酸、外用过氧化氢与单纯伤口护理三种治疗。
主要发现
- 参与者被随机分配到三种治疗之一,疗程5天,主要结局为通过配对照片由对治疗分组设盲的评分者评估的临床改善。
- 试验还比较治疗前后的抗菌药物耐药模式。
关键数值与推荐
- 主要结局为临床改善,通过配对照片由对治疗分组设盲的评分者评估。
- 参与者随机接受5天治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Impetigo is a common and contagious bacterial skin infection, affecting children worldwide, but it is particularly prevalent in socioeconomically disadvantaged communities. In New Zealand, widespread prescribing of the topical antibiotic fusidic acid had led to an increase in antimicrobial resistance of Staphylococcus aureus. Alternative treatments are urgently being sought, and as impetigo is a superficial infection, it has been suggested that topical antiseptics such as hydrogen peroxide or simple wound care alone may treat impetigo while avoiding the risk of increased antimicrobial resistance. METHODS: This protocol for a non-inferiority, single-blind randomised controlled trial compares topical fusidic acid with topical hydrogen peroxide and with simple wound care in the treatment of childhood impetigo. Participants are randomised to one of the three treatments for 5 days. The primary outcome is clinical improvement assessed through paired photographs analysed by graders blinded to treatment arm. The trial is based in school health clinics in an urban centre in New Zealand. Comparison of antimicrobial resistance patterns pre- and post-treatment is also performed. DISCUSSION: Special note is made of the need to involve the communities most affected by impetigo in the design and implementation of the clinical trial to recruit the children most in need of safe and effective treatments. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR) 12616000356460 . Registered on March 10, 2016 Protocol amendment number: 05 EB and AL contributed equally as senior authors.
引用
- Primhak S, Gataua A, Purvis D, et al. Treatment of Impetigo with Antiseptics-Replacing Antibiotics (TIARA) trial: a single blind randomised controlled trial in school health clinics within socioeconomically disadvantaged communities in New Zealand. Trials. 2022. PMID: 35109906. doi:10.1186/s13063-022-06042-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。